Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pfizer acquires Switzerland's Redvax GmbH
Tuesday, January 06, 2015Pfizer Inc announced that it has acquired a controlling interest in Redvax GmbH a spinoff from Redbiotec AG a privately held Swiss biopharmaceutical company based in ZurichSchlieren This transaction provides access to a preclinical human cytomegalovi...
Catamaran completes acquisition of Salveo Specialty Pharmacy for $260 million
Monday, January 05, 2015Catamaran Corp a leading provider of pharmacy benefit management PBM services and technology solutions announced today the completion effective as of January of its previously disclosed acquisition of Salveo Specialty Pharmacy for a purchase price...
Adapt Pharma invests in Maynooth University tech spin-off
Monday, January 05, 2015Adapt Pharma the latest venture of serial pharmaceuticals entrepreneur Samus Mulligan has invested in a hightech medical devices business spun out from Maynooth University Profector Life Sciences founded in has a scientific instruments business sel...
Knight Therapeutics Inc. and NeurAxon Inc. form Partnership for the Commercialization of NeurAxon's Innovative Products
Friday, January 02, 2015Knight Therapeutics Inc a leading Canadian specialty pharmaceutical company today announced that it has entered into a strategic partnership with NeurAxon Inc NeurAxon for the commercialization of NeurAxons innovative products in various stages of de...
Pharma and biotech on a roll as drug approvals hit 18-year high
Friday, January 02, 2015US drug approvals in hit their highest level in years and recommendations in Europe also came at a rapid rate driven by expensive new treatments for cancer and rare diseases After suffering a wave of patent losses on blockbuster products which pea...
BioMarin announces approval of VIMIZIM(R) (elosulfase alfa) in Japan for Treatment of Morquio A Syndrome
Tuesday, December 30, 2014BioMarin Pharmaceutical Inc today announced the Ministry of Health Labor and Welfare granted approval of the registration of VIMIZIM elosulfase alfa for the treatment of patients with mucopolysaccharidosis type IVA MPS IVA also known as Morquio A syn...
ARIAD announces Commercialization agreement for Iclusig in Seven Central and Eastern European Countries
Tuesday, December 30, 2014ARIAD Pharmaceuticals Inc and Angelini Pharma through the Austrian subsidiary CSC Pharmaceuticals today announced that ARIAD has granted Angelini exclusive rights to commercialize Iclusig ponatinib for the indications approved by the European Medicin...
MIV-802 has been selected as a candidate drug and enters non-clinical development for the treatment of hepatitis C infection
Monday, December 22, 2014Medivir AB announced that MIV has been selected as a candidate drug CD from its hepatitis C virus HCV nucleotide polymerase inhibitor project for the treatment of HCV infection and is entering nonclinical development Approximately million people a...
Swissmedic approves Basilea''s antibiotic Zevtera(r) (ceftobiprole medocaril) for the treatment of pneumonia
Monday, December 22, 2014Basilea Pharmaceutica Ltd reports that the Swiss regulatory authority Swissmedic has approved the antibiotic Zevtera ceftobiprole medocaril for the treatment in adults of communityacquired pneumonia CAP and hospitalacquired pneumonia HAP excluding ve...
Roche to pay up to $489 mln for next-generation antibody developer Dutalys
Saturday, December 20, 2014Roche has agreed to pay up to million to acquire Austrian biotech company Dutalys a specialist in the discovery and development of socalled bispecific antibodies the Swiss drugmaker said on Thursday Bispecific antibody therapy is a fastemerging te...
